[177Lu]Lu-EVS459

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [177Lu]Lu-EVS459, covering 2025-08-07 to 2025-08-07. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers [Phase 1]